Teladoc Health, Inc. (NYSE:TDOC) Receives $7.43 Average Price Target from Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC) have earned a consensus rating of “Hold” from the seventeen analysts that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $7.4333.

Several equities analysts recently issued reports on TDOC shares. Bank of America upgraded Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 price target on the stock in a research report on Thursday, February 26th. Citigroup raised their target price on shares of Teladoc Health from $6.00 to $7.00 and gave the stock a “neutral” rating in a report on Tuesday, May 5th. Wells Fargo & Company lowered their price objective on shares of Teladoc Health from $8.00 to $6.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 26th. JPMorgan Chase & Co. decreased their target price on shares of Teladoc Health from $9.00 to $7.00 and set a “neutral” rating for the company in a research note on Friday, March 13th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $9.00 target price (down from $12.00) on shares of Teladoc Health in a report on Thursday, February 26th.

Insider Activity

In other Teladoc Health news, insider Carlos Nueno sold 6,196 shares of Teladoc Health stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $47,275.48. Following the completion of the sale, the insider owned 57,671 shares in the company, valued at $440,029.73. The trade was a 9.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Fernando M. Rodrigues sold 5,677 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $43,315.51. Following the sale, the insider directly owned 9,572 shares in the company, valued at $73,034.36. The trade was a 37.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 39,870 shares of company stock worth $302,507. 0.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Teladoc Health

A number of hedge funds have recently bought and sold shares of TDOC. EverSource Wealth Advisors LLC increased its position in shares of Teladoc Health by 694.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 4,945 shares during the last quarter. PNC Financial Services Group Inc. lifted its holdings in Teladoc Health by 177.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 2,810 shares during the period. IFP Advisors Inc raised its stake in shares of Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after buying an additional 3,210 shares during the period. Aster Capital Management DIFC Ltd increased its position in shares of Teladoc Health by 101.1% during the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after purchasing an additional 2,425 shares in the last quarter. Finally, International Assets Investment Management LLC purchased a new stake in Teladoc Health in the 4th quarter valued at $45,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Trading Up 0.3%

TDOC opened at $7.59 on Thursday. The stock has a fifty day moving average price of $6.52 and a 200-day moving average price of $6.23. Teladoc Health has a 12 month low of $4.40 and a 12 month high of $9.77. The firm has a market cap of $1.37 billion, a price-to-earnings ratio of -7.83 and a beta of 2.14. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Wednesday, April 29th. The health services provider reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.The company had revenue of $613.85 million during the quarter, compared to analysts’ expectations of $611.04 million. During the same quarter in the previous year, the company earned ($0.53) EPS. The firm’s quarterly revenue was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. As a group, equities research analysts anticipate that Teladoc Health will post -0.92 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.